Sector
PharmaceuticalsOpen
₹942.75Prev. Close
₹942.75Turnover(Lac.)
₹775.8Day's High
₹1,004.8Day's Low
₹941.252 Week's High
₹1,07852 Week's Low
₹535Book Value
₹95.48Face Value
₹10Mkt Cap (₹ Cr.)
2,897.09P/E
335.97EPS
2.93Divi. Yield
0.1Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 25.85 | 25.16 | 25.16 | 24.56 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 95.93 | 69.3 | 66.21 | 41.81 |
Net Worth | 121.78 | 94.46 | 91.37 | 66.37 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 106.84 | 95.08 | 85.62 | 77.84 |
yoy growth (%) | 12.36 | 11.03 | 10 | 8.75 |
Raw materials | -73.34 | -66.3 | -57.01 | -51.03 |
As % of sales | 68.64 | 69.72 | 66.58 | 65.56 |
Employee costs | -9.3 | -10.34 | -8.89 | -6.63 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | -1.34 | 3.88 | 7.85 | 11.36 |
Depreciation | -3.16 | -2.09 | -1.39 | -0.93 |
Tax paid | 0.15 | -1.12 | -2.3 | -4.07 |
Working capital | 2.77 | -2.38 | 8.18 | 12.04 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 12.36 | 11.03 | 10 | 8.75 |
Op profit growth | -85.09 | -41.46 | -28.94 | 8.56 |
EBIT growth | -131.25 | -49.98 | -31.23 | 26.97 |
Net profit growth | -105.88 | -50.28 | -23.6 | 31.15 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 292.97 | 180.49 | 139.96 | 131.19 | 106.79 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 292.97 | 180.49 | 139.96 | 131.19 | 106.79 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.07 | 1.16 | 2.49 | 1.63 | 2.29 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Ketankumar Zota
Managing Director
Moxesh Zota
Whole-time Director
Kamlesh Zota
Whole-time Director
Himanshu Zota
Whole-time Director
Manukant Zota
Independent Director
Varsaben Mehta
Company Secretary
Ashvin Variya
Addtnl Independent Director
Bhumi Maulik Doshi
Independent Director
Dhiren Prafulbhai Shah
Independent Director
Jayshreeben N Mehta
Zota House 2/896 Hira Modi St,
Sagrampura,
Gujarat - 395002
Tel: 91-261-2331601
Website: http://www.zotahealthcare.com
Email: [email protected]
Unit-49 Bldg-13 AB,
Off Andheri Kurla Rd, MTNL Lane Sakinaka,
Mumbai-400072
Tel: 91-22-28520461
Website: www.satellitecorporate.com
Email: [email protected]
Summary
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products. The Company was inc...
Read More
Reports by Zota Health Care Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.